Statement 1.1: Initial identification of primary non-response or loss of response after initial improvement is based on signs and symptoms, biomarkers and global assessment of the patient’s condition, including extraintestinal manifestations, by the treating physician (Evidence level 1a)

Voting agreement rate 41/46 (89.1%)